Indah Prakasa Sentosa Tbk vs Merck Tbk. — how do they compare? Indah Prakasa Sentosa Tbk trades at Rp590 (market cap 377B, 516.1K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 4.5× Indah Prakasa Sentosa Tbk's market cap, and Indah Prakasa Sentosa Tbk is more actively traded (516.1K versus 37.6K). Which is the better fit depends on your goals.
| INPS | MERK | |
|---|---|---|
Market Cap | 377B | 1.7T |
Volume | 516.1K | 37.6K |
Lot | 5.16K | 376 |
Turnover | 283.08M | 144.47M |
Average Price | 548.49 | 3,842.23 |
Value | 283.08M | 144.47M |
Indicative Equilibrium Price | 590 | 3,840 |
Indicative Equilibrium Volume | 102 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indah Prakasa Sentosa Tbk (the "Company”) was established based on Notarial Deed No. 44 dated January 15, 1988 of Bachruddin Hardigaluh, S.H., Notary in Cirebon.
Read more on INPS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →